BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PTCMA - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PTCMA
X-ORIGINAL-URL:https://ptcma.org.za
X-WR-CALDESC:Events for PTCMA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20250312T083000
DTEND;TZID=Africa/Johannesburg:20250312T100000
DTSTAMP:20250305T092847Z
CREATED:20250304T125813Z
LAST-MODIFIED:20250305T092847Z
UID:12336-1741768200-1741773600@ptcma.org.za
SUMMARY:Virtual CPD – 12 March 2025
DESCRIPTION:Programme\n08h45: Login and sound check \n09h00: Homologous Recombination Deficiency (HRD) and Ovarian Cancer: Bridging Research and Clinical Practice \nPresented by: Dr Lizanne Langenhoven (Radiation Oncologist) \n  \n\n\n\n\nClick to register\n\n\n\n\n\n\nThank you to AstraZeneca for providing the unconditional educational sponsorship\, making this session possible.
URL:https://ptcma.org.za/event/vcpd-12-march-2025/
CATEGORIES:Morning,VCPD
ATTACH;FMTTYPE=image/jpeg:https://ptcma.org.za/wp-content/uploads/2024/01/Ovarian-cancer-600x400-1.jpg
END:VEVENT
END:VCALENDAR